PMC:7228307 / 42051-42243 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"714","span":{"begin":113,"end":121},"obj":"Gene"},{"id":"719","span":{"begin":94,"end":98},"obj":"Gene"},{"id":"722","span":{"begin":180,"end":185},"obj":"Disease"}],"attributes":[{"id":"A714","pred":"tao:has_database_id","subj":"714","obj":"Gene:2214"},{"id":"A719","pred":"tao:has_database_id","subj":"719","obj":"Gene:2213"},{"id":"A722","pred":"tao:has_database_id","subj":"722","obj":"MESH:D009369"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"First, improving activation potency by selectively enhancing interaction with activating‐type FcγR, particularly FcγRIIIa owing to its predominant role in ADCC‐mediated killing of tumor cells."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T359","span":{"begin":186,"end":191},"obj":"Body_part"}],"attributes":[{"id":"A359","pred":"fma_id","subj":"T359","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"First, improving activation potency by selectively enhancing interaction with activating‐type FcγR, particularly FcγRIIIa owing to its predominant role in ADCC‐mediated killing of tumor cells."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T68","span":{"begin":155,"end":159},"obj":"Disease"},{"id":"T69","span":{"begin":180,"end":185},"obj":"Disease"}],"attributes":[{"id":"A68","pred":"mondo_id","subj":"T68","obj":"http://purl.obolibrary.org/obo/MONDO_0008734"},{"id":"A69","pred":"mondo_id","subj":"T69","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"}],"text":"First, improving activation potency by selectively enhancing interaction with activating‐type FcγR, particularly FcγRIIIa owing to its predominant role in ADCC‐mediated killing of tumor cells."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T754","span":{"begin":17,"end":27},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T755","span":{"begin":78,"end":88},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T756","span":{"begin":94,"end":96},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T757","span":{"begin":113,"end":115},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T758","span":{"begin":186,"end":191},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"First, improving activation potency by selectively enhancing interaction with activating‐type FcγR, particularly FcγRIIIa owing to its predominant role in ADCC‐mediated killing of tumor cells."}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T212","span":{"begin":186,"end":191},"obj":"http://purl.obolibrary.org/obo/CL_0000000"}],"text":"First, improving activation potency by selectively enhancing interaction with activating‐type FcγR, particularly FcγRIIIa owing to its predominant role in ADCC‐mediated killing of tumor cells."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"714","span":{"begin":113,"end":121},"obj":"Gene"},{"id":"719","span":{"begin":94,"end":98},"obj":"Gene"},{"id":"722","span":{"begin":180,"end":185},"obj":"Disease"}],"attributes":[{"id":"A714","pred":"pubann:denotes","subj":"714","obj":"Gene:2214"},{"id":"A719","pred":"pubann:denotes","subj":"719","obj":"Gene:2213"},{"id":"A722","pred":"pubann:denotes","subj":"722","obj":"MESH:D009369"}],"text":"First, improving activation potency by selectively enhancing interaction with activating‐type FcγR, particularly FcγRIIIa owing to its predominant role in ADCC‐mediated killing of tumor cells."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T236","span":{"begin":0,"end":192},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"First, improving activation potency by selectively enhancing interaction with activating‐type FcγR, particularly FcγRIIIa owing to its predominant role in ADCC‐mediated killing of tumor cells."}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T358","span":{"begin":186,"end":191},"obj":"Body_part"}],"attributes":[{"id":"A358","pred":"fma_id","subj":"T358","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"First, improving activation potency by selectively enhancing interaction with activating‐type FcγR, particularly FcγRIIIa owing to its predominant role in ADCC‐mediated killing of tumor cells."}

{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T106","span":{"begin":155,"end":159},"obj":"http://purl.obolibrary.org/obo/GO_0001788"}],"text":"First, improving activation potency by selectively enhancing interaction with activating‐type FcγR, particularly FcγRIIIa owing to its predominant role in ADCC‐mediated killing of tumor cells."}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T25","span":{"begin":180,"end":185},"obj":"Disease"}],"attributes":[{"id":"A25","pred":"mondo_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"}],"text":"First, improving activation potency by selectively enhancing interaction with activating‐type FcγR, particularly FcγRIIIa owing to its predominant role in ADCC‐mediated killing of tumor cells."}

{"project":"LitCovid-sample-PD-HP","denotations":[{"id":"T15","span":{"begin":180,"end":185},"obj":"Phenotype"}],"attributes":[{"id":"A15","pred":"hp_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"First, improving activation potency by selectively enhancing interaction with activating‐type FcγR, particularly FcγRIIIa owing to its predominant role in ADCC‐mediated killing of tumor cells."}

{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T106","span":{"begin":155,"end":159},"obj":"http://purl.obolibrary.org/obo/GO_0001788"}],"text":"First, improving activation potency by selectively enhancing interaction with activating‐type FcγR, particularly FcγRIIIa owing to its predominant role in ADCC‐mediated killing of tumor cells."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T106","span":{"begin":155,"end":159},"obj":"http://purl.obolibrary.org/obo/GO_0001788"}],"text":"First, improving activation potency by selectively enhancing interaction with activating‐type FcγR, particularly FcγRIIIa owing to its predominant role in ADCC‐mediated killing of tumor cells."}

{"project":"LitCovid-sentences","denotations":[{"id":"T236","span":{"begin":0,"end":192},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"First, improving activation potency by selectively enhancing interaction with activating‐type FcγR, particularly FcγRIIIa owing to its predominant role in ADCC‐mediated killing of tumor cells."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T15","span":{"begin":180,"end":185},"obj":"Phenotype"}],"attributes":[{"id":"A15","pred":"hp_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"First, improving activation potency by selectively enhancing interaction with activating‐type FcγR, particularly FcγRIIIa owing to its predominant role in ADCC‐mediated killing of tumor cells."}